Furthermore, anti-VEGF ocular therapy can produce tachyphylaxis, and systemic side effects have been reported, including hypertension, stroke, thromboembolic events, myocardial infarction, gastrointestinal perforations and kidney disease [201]. Here, VEGFA is linked to stroke disorder.